Investing.com - Avita Medical (NASDAQ:RCEL) reported on Monday fourth quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Avita Medical announced earnings per share of $-0.34 on revenue of $6.94M. Analysts polled by Investing.com anticipated EPS of $-0.3172 on revenue of $7.16M.
Avita Medical shares are down 23.21% from the beginning of the year, still down 63.20% from its 52 week high of $25.00 set on March 3, 2021. They are under-performing the Nasdaq which is down 12.1% from the start of the year.
Avita Medical follows other major Healthcare sector earnings this month
Avita Medical's report follows an earnings matched by Roche Holding ADR on February 3, who reported EPS of $1.29 on revenue of $17.54B, compared to forecasts EPS of $1.29 on revenue of $17.1B.
Pfizer had beat expectations on February 8 with fourth quarter EPS of $1.08 on revenue of $23.84B, compared to forecast for EPS of $0.8742 on revenue of $24.16B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar